Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Proschan

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Statistics in Medicine|September 11, 2012
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?Michael Proschan, Charles E Ford, Jeffrey A Cutler, et al.
Controlled Clinical Trials|December 31, 2002
Women's angiographic vitamin and estrogen trial: design and methodsJudith Hsia, Edwin L Alderman, Joel I Verter, et al.
JAMA|November 19, 2002
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trialDavid D Waters, Edwin L Alderman, Judith Hsia, et al.
Journal of Clinical and Translational Science|December 2, 2024
Erratum: The statistical design and analysis of pandemic platform trials: Implications for the future - CORRIGENDUMChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.
Journal of Clinical and Translational Science|November 14, 2024
The statistical design and analysis of pandemic platform trials: Implications for the futureChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.
Frontiers in Medicine|September 8, 2022
Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruptionChuen-Yen Lau, Matthew A Adan, Jessica Earhart, et al.
Annals of Internal Medicine|November 24, 2015
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized TrialAnita Kohli, Sarah Kattakuzhy, Sreetha Sidharthan, et al.
Journal of Clinical and Translational Science|October 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemicMaryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas, et al.
Lancet (London, England)|March 18, 2014
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trialNita Bhandari, Temsunaro Rongsen-Chandola, Ashish Bavdekar, et al.
Vaccine|August 6, 2014
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of lifeNita Bhandari, Temsunaro Rongsen-Chandola, Ashish Bavdekar, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Statistics in Medicine|September 11, 2012
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?Michael Proschan, Charles E Ford, Jeffrey A Cutler, et al.
Controlled Clinical Trials|December 31, 2002
Women's angiographic vitamin and estrogen trial: design and methodsJudith Hsia, Edwin L Alderman, Joel I Verter, et al.
JAMA|November 19, 2002
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trialDavid D Waters, Edwin L Alderman, Judith Hsia, et al.
Journal of Clinical and Translational Science|December 2, 2024
Erratum: The statistical design and analysis of pandemic platform trials: Implications for the future - CORRIGENDUMChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.
Journal of Clinical and Translational Science|November 14, 2024
The statistical design and analysis of pandemic platform trials: Implications for the futureChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.
Frontiers in Medicine|September 8, 2022
Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruptionChuen-Yen Lau, Matthew A Adan, Jessica Earhart, et al.
Annals of Internal Medicine|November 24, 2015
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized TrialAnita Kohli, Sarah Kattakuzhy, Sreetha Sidharthan, et al.
Journal of Clinical and Translational Science|October 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemicMaryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas, et al.
Lancet (London, England)|March 18, 2014
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trialNita Bhandari, Temsunaro Rongsen-Chandola, Ashish Bavdekar, et al.
Vaccine|August 6, 2014
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of lifeNita Bhandari, Temsunaro Rongsen-Chandola, Ashish Bavdekar, et al.
Pageof 6